![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
HCV and HBV prevalence and associated risk factors among people who inject drugs in Kenya
|
|
|
EASL 2023 june 21-24 vienna
Matthew J. Akiyama, MD, MSc 1, Lindsey Riback1, Mercy Nyakowa2, Chenshu Zhang1, Sarah Masyuko2, Rose Wafula2, Nazila Ganatra2
1. Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA
2. National AIDS & STI Control Program (NASCOP),Kenya Ministry of Health, Nairobi, Kenya
![0705231](../images/070523/070523-29/0705231.gif)
![0705232](../images/070523/070523-29/0705232.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|